Top Markets
#1 Nesa Nesa +787.23%
#2 Cortex Cortex +68.85%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.81%
#4 Pons Pons +28.40%
#5 QuantixAI QuantixAI +23.66%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +17.69%
#8 Movement Movement +14.84%
#9 The Black Bull The Black Bull +14.43%
#10 Magma Finance Magma Finance +12.32%
Coin of the day
Nesa Nesa
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Surrozen, Inc. Surrozen, Inc.

Surrozen, Inc.

SRZN
Clasificación en acciones #19464
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates... Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs’ endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Precio por acción
$21.57
Última sincronización: 2026-07-31
Capitalización bursátil
$161.29M
Cambio (1 día)
3.55%
Cambio (1 año)
94.32%
País
US
Comercio Surrozen, Inc. (SRZN)

Categoría

Healthcare
Historial del precio de la acción de Surrozen, Inc. (SRZN)
Precio más alto de cierre: $22.02 el 2026-07-01

Precio más bajo de cierre: $154.45 el 2021-01-01
Historial del precio de la acción de Surrozen, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.48%
2025 90.61%
2024 37.87%
2023 6.62%
2022 -93.19%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.23 -12.55%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH